Hemocompatible Adsorbent Granules for Protein-Bound Toxin Removal

Resolve Bottlenecks,
Find Innovative Solutions
Generate Solutions

Solution Overview

Problem

Current hemodialysis methods are inefficient in removing protein-bound uremic toxins due to their hydrophobic nature and the hemocompatibility issues of existing adsorber materials, which can lead to blood clotting and embolisms.

Innovation Solution

Development of hemocompatible adsorber granules with spherical activated carbon particles coated with a cross-linked hydrophilic polymer layer, specifically polyvinylpyrrolidone, to effectively remove protein-bound toxins while ensuring biocompatibility.

Engineering Contradictions & Design Principles

VSEngineering Contradiction Analysis

1Quantity of substance

If activated carbon or styrene-divinylbenzene copolymer adsorbers are used to remove toxins from blood, then toxin adsorption capacity is improved, but hemocompatibility deteriorates leading to blood clotting and complement activation

Engineering Contradiction:
Improvetoxin adsorption capacityVSAvoidhemocompatibility
Core Design Contradiction:
Quantity of substanceVSObject-affected harmful factors

Solution Approach 1:

The invention uses a composite structure consisting of a styrene-divinylbenzene copolymer core (for toxin adsorption) coated with a hydrophilic polymer layer (for hemocompatibility). This composite material combines the advantages of both materials: the hydrophobic core provides high toxin adsorption capacity while the hydrophilic coating prevents blood clotting and complement activation.

Inventive Principle:
Principle #40Composite materials

Solution Approach 2:

A thin hydrophilic polymer coating is applied over the hydrophobic adsorber core. This thin film acts as a protective barrier that maintains hemocompatibility while allowing the underlying adsorber material to function. The coating is thin enough to not significantly reduce adsorption capacity but thick enough to prevent direct blood contact with the hydrophobic surface.

Inventive Principle:
Principle #30Flexible shells and thin films

2Productivity

If hydrophobic adsorber materials are used to adsorb protein-bound uremic toxins, then adsorption effectiveness is improved, but blood clotting and embolism risks increase

Engineering Contradiction:
Improveadsorption effectivenessVSAvoidblood clotting and embolism
Core Design Contradiction:
ProductivityVSObject-generated harmful factors

Solution Approach 1:

The hydrophilic polymer coating acts as an intermediary layer between the hydrophobic adsorber core and the blood. It mediates the interaction by preventing direct contact between blood components and the hydrophobic surface, thereby eliminating blood clotting and embolism risks while allowing the core to maintain its adsorption effectiveness.

Inventive Principle:
Principle #24Intermediary (Mediator)

3Productivity

If hemodialysis is used to remove water-soluble toxins, then removal efficiency is improved, but protein-bound hydrophobic toxins cannot be effectively removed

Engineering Contradiction:
Improvetoxin removal efficiencyVSAvoidtoxin type coverage
Core Design Contradiction:
ProductivityVSAdaptability or versatility

Solution Approach 1:

The invention changes the surface property parameter of the adsorber material from hydrophobic to hydrophilic through polymer coating. This parameter change enables the adsorber to interact effectively with protein-bound hydrophobic toxins that cannot be removed by conventional hemodialysis, while maintaining biocompatibility for clinical use.

Inventive Principle:
Principle #35Parameter changes

Applied Scientific Principles

This section explains which scientific principles are used to turn an abstract innovation direction into a practical engineering solution.

Function Achieved in This Case

The adsorber granules demonstrate enhanced hemocompatibility and effective adsorption of uremic toxins, including protein-bound ones, without triggering blood clotting or embolisms, thereby improving the treatment of chronic kidney failure and liver insufficiency.

Implementation Method 1

Another option for removing toxins from blood or blood plasma is to bind the toxins to a hydrophobic adsorber

Methodology Applied
Scientific EffectAdsorption: Adsorption

Implementation Method 2

The adsorbers used to remove toxins from blood are made of activated carbon or styrene-divinylbenzene copolymer

Methodology Applied
Scientific EffectHydrophobic interaction: Hydrophobe

Data Source

PatentEP3116644B1Granular adsorbents for removal of uremic toxins
Publication Date: 2019.02.27 FRESENIUS MEDICAL CARE DEUTSCHLAND GMBH
  • EP3116644B1 patent drawingFigure 1~2
  • EP3116644B1 patent drawingFigure 3~4
  • EP3116644B1 patent drawing

AI summary

The present invention relates to hemocompatible adsorber materials for removing protein-bound toxins from blood or blood plasma, comprising spherical activated carbon particles that are coated with a hydrophilic, cross-linked polymer layer. The present invention further relates to a method for producing said adsorber materials and to the use thereof in renal or hepatic replacement therapy, for detoxification and in the treatment of sepsis.